The clinical relevance of the anti-inflammatory properties of antihistamines
Article first published online: 23 SEP 2008
Volume 55, Issue Supplement supp60, pages 53–61, May 2000
How to Cite
Walsh, G. M. (2000), The clinical relevance of the anti-inflammatory properties of antihistamines. Allergy, 55: 53–61. doi: 10.1034/j.1398-9995.2000.00009.x
- Issue published online: 23 SEP 2008
- Article first published online: 23 SEP 2008
- 1ISAAC. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, atopic eczema. Lancet 1998;351:1225–1232.
- 2Epidemiology and natural history of asthma, allergic rhinitis and atopic dermatitis. In: MiddletonEJr, ReedCE, EllisEF, AdkinsonNfJr, YungingerJW, BusseWW, editors. Allergy: principles and practice. 4th ed. St Louis, MO: Mosby, 1993:1109–1136..
- 3T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992;13:501–506., .
- 4IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988;140:4193–4198., , , et al.
- 5Interleukin-5, eosinophils and disease. Blood 1992;79:3101–3109..
- 6TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145–173., .
- 7Th1 and Th2 CD4+ cells in human allergic diseases. J Allergy Clin Immunol 1997;100:1–6., .
- 8Human eosinophils: their accumulation, activation and fate. Br J Haematol 1997;97:701–709..
- 9Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033–1035., , , et al.
- 10The eosinophil; structure and functions. In: KaplanAP, editor. Allergy. Philadelphia, PA: Saunders, 1997:148., .
- 11Skin eosinophilia in atopic patients. J Allergy Clin Immunol 1988;81:691–695., .
- 12Eosinophil activation and T lymphocyte infiltration in allergen-induced late phase skin reactions and classical delayed type hypersensitivity. J Immunol 1991;147:816–822., , , et al.
- 13A current perspective on the roles of eosinophils in dermatologic diseases. J Am Acad Dermatol 1991;24:1101–1112..
- 14Eicosanoids, cytokines and other mediators elaborated by eosinophils. In: MakinoS, FukudaT, editors. Eosinophils, biological and clinical aspects. Boca Raton, FL: CRC Press, 1993:125–154..
- 15Cytokine generation by eosinophils. J Allergy Clin Immunol 1994;94:1183–1188., , .
- 16H1 receptor antagonists: anti-allergic effects in vitro. In: SimonsFER, editor. Histamine and H1-receptor antagonists in allergic disease. Clinical Allergy and Immunology Series. New York: Marcel Dekker, 1996:117–144., , .
- 17H1 receptor antagonists: antiallergic effects in humans. In: SimonsFER, editor. Histamine and H1-receptor antagonists in allergic disease. Clinical Allergy and Immunology Series. New York: Marcel Dekker, 1996:145–174., .
- 18Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo. Clin Allergy 1987;17:373–379., , , .
- 19In vivo effects of cetirizine on cutaneous reactivity and eosinophil migration induced by platelet activating factor in man. J Allergy Clin Immunol 1990;86:314–320., , , , , .
- 20Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-aceter release and eosinophil recruitment in human skin. J Allergy Clin Immunol 1988;82:101–109., , , , , .
- 21Effect of cetirizine on mast cell mediator release and cellular traffic during the cutaneous late-phase reaction. J Allergy Clin Immunol 1989;83:905–912., , , .
- 22Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge. J Pharmacol Exp Ther 1992;262:964–970., , , , .
- 23Effects of antihistamines on cutaneous reactions and influx of eosinophils after local injection of PAF, kallikrein, compound 48/80 and histamine in patients with chronic urticaria and healthy subjects. Acta Derm Venereol 1992;72:197–200., .
- 24Effects of loratadine on anti-IgE-induced inflammation, histamine release and leukocyte recruitment in skin of atopics. Allergy 1995;50:414–420., , , et al.
- 25The effect of a single oral dose of prednisolone or cetirizine on inflammatory cells infiltrating allergen-induced cutaneous late-phase reactions in atopic subjects. Clin Exp Allergy 1992;22:43–49., , , , .
- 26Effect of cetirizine and prednisolone on cellular infiltration and cytokine mRNA expression during allergen-induced late cutaneous responses. Clin Exp Allergy 1996;26:69–78., , , et al.
- 27The effects of cetirizine on the function of inflammatory cells involved in the allergic response. Clin Exp Allergy 1997;27:47–53..
- 28Effect of loratadine on human eosinophil function in vitro. Ann Allergy 1993;71:373–378., , , , .
- 29Effect of terfenadine on human eosinophil and neutrophil chemotactic response and generation of superoxide. Ann Allergy 1994;73:154–160., , .
- 30Inhibition of eosinophil chemotaxis by a new antiallergic compound (cetirizine). Int Arch Allergy Appl Immunol 1988;87:9–13., , , , .
- 31Inhibition of human eosinophil chemotaxis and of the IgE-dependent stimulation of human blood platelets by cetirizine. Int Arch Allergy Appl Immunol 1989;88:212–215., , , et al.
- 32Cetirizine inhibits the in vitro and ex vivo chemotactic responses of T lymphocytes and monocytes. J Allergy Clin Immunol 1995;95:979–986., , , , , .
- 33Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis. J Allergy Clin Immunol 1998;101:410–420., , , , , .
- 34Modulation of human eosinophil chemotaxis and adhesion by antiallergic drugs in vitro. Pediatr Allergy Immunol 1993;4 Suppl 4:13–18., , , et al.
- 35Effects of cetirizine on human eosinophil and neutrophil activation in vitro. Int Arch Allergy Appl Immunol 1991;95:158–162., , , .
- 36Antihistamines: time to reappraise for a new millennium? Drugs 2000 (in press)., , , et al.
- 37Effect of cetirizine on human eosinophil superoxide generation, eosinophil chemotaxis and eosinophil peroxidase in vitro. Int Arch Allergy Immunol 1994;103:384–390., , , et al.
- 38Leukotriene B4 in inflammation. Immunology 1990;10:1–12..
- 39Leukotriene B4 levels in stimulated blood neutrophils and alveolar macrophages from healthy and asthmatic subjects. Effect of beta-2 agonist therapy. Eur J Clin Invest 1992;22:732–739., , , et al.
- 40Leukotriene B4 production by blood neutrophils in allergic rhinitis – effects of cetirizine. Clin Exp Allergy 1995;25:729–736., , , et al.
- 41A study of the interaction between cetirizine and plasma membrane of eosinophils, neutrophils, platelets and lymphocytes using a fluorescence technique. Mediators Inflamm 1994;3:229–234., , , .
- 42The bronchial epithelium as a target for inflammatory attack in asthma. Clin Exp Allergy 1992;22:511–520., , , .
- 43Allergic subjects express intercellular adhesion molecule-1 (ICAM-1 or CD54) on epithelial cells of conjunctiva after allergen challenge. J Allergy Clin Immunol 1993;91:783–792., , , , , .
- 44Cetirizine reduces inflammatory cell recruitment and ICAM-1 (CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge. J Allergy Clin Immunol 1995;95:612–621., , , et al.
- 45Oxatomide reduces inflammatory events induced by allergen-specific conjunctival challenge. Ann Allergy 1995;75:446–452., , , et al.
- 46Protective effect of loratadine on late phase reaction induced by conjunctival provocation test. Int Arch Allergy Appl Immunol 1992;907:1–5., , , , , .
- 47Protective effect of terfenadine at different dosage on conjunctival provocation test. Allergy 1992;47:309–312., , , .
- 48Cetirizine reduces ICAM-1 on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with mite-allergic asthma. Int Arch Allergy Immunol 1996;109:272–276., , , et al.
- 49Effect of cetirizine on nasal polyps and their associated symptoms [Abstract]. Allergy 1995;50:103., , , , , .
- 50Mucosal inflammation in asthma. Am Rev Respir Dis 1990;142:434–457., , , et al.
- 51Bronchial biopsies in asthma. Am Rev Respir Dis 1989;140:1745–1753., , , , .
- 52Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. J Allergy Clin Immunol 1995;96:971–979., , , et al.
- 53A cell adhesion molecule ICAM-1 is the major surface receptor for rhinoviruses. Cell 1989;56:849., , , , , .
- 54Viruses as precipitants of asthma symptoms. II. Physiology and mechanisms. Clin Exp Allergy 1992;22:809–822., , .
- 55Viruses as precipitants of asthma symptoms. I. Epidemiology. Clin Exp Allergy 1992;22:325–336., , .
- 56ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation. Int Arch Allergy Immunol 1995;107:99–102., , , , , .
- 57Upper airway inflammatory diseases and bronchial hyperresponsiveness. J Allergy Clin Immunol 1988;81:1036–1041..
- 58Cetirizine reduces ICAM-1 on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with mite-allergic asthma. Int Arch Allergy Immunol 1996;109:272–276., , , et al.
- 59Antihistamines in asthma. J Allergy Clin Immunol 1989;83:537–547., .
- 60To use or not to use antihistamines in patients with asthma. [Editorial] Ann Allergy 1990;64:183–186..
- 61Spontaneous histamine-release and histamine content in normal subjects and subjects with asthma. J Allergy Clin Immunol 1989;83:742–749., .
- 62Direct evidence of a role for mast cells in pathogenesis of antigen-induced bronchoconstriction. J Clin Invest 1987;80:1507–1511., , .
- 63Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness. J Clin Invest 1987;79:1197–1203., , .
- 64Antihistamines in the treatment of asthma. Allergy 1997;52 Suppl 34:55., .
- 65The comparative actions and adverse effect profile of single doses of H1-receptor antihistamines in the airways and skin of subjects with asthma. J Allergy Clin Immunol 1993;91:1005–1014., .
- 66Dose-response relationship of the H1-histamine antagonist, ebastine, against histamine- and methacholine-induced bronchoconstriction in patients with asthma. Agents Actions 1990;30(1–2):284–286., .
- 67The effects of a new generation of H1 antihistamines (cetirizine and loratadine) on histamine release and the bronchial response to histamine in atopic patients. J Investig Allergol Clin Immunol 1995;5:103–107., , .
- 68Effect of cetirizine, a potent H1 antagonist, on platelet activating factor induced bronchoconstriction in asthma. Clin Exp Allergy 1993;23:524–527., , , .
- 69Inhibitory effect of cetirizine on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma. J Allergy Clin Immunol 1992;90:215–224., , , et al.
- 70Effect of cetirizine, a new H1 antihistamine, on the early and late allergic reactions in a bronchial provocation test with allergen. J Allergy Clin Immunol 1993;91:1189–1197., , .
- 71Protective effect of cetirizine in patients suffering from pollen asthma. Ann Allergy 1990;64:224–228., , , .
- 72Double-blind multicenter study of cetirizine in grass-pollen-induced asthma. Ann Allergy 1990;65:504–508., , , et al.
- 73Prophylactic treatment of grass pollen-induced asthma with cetirizine. Clin Exp Allergy 1990;20:483–490., , , et al.
- 74Effect of oral and inhaled cetirizine in allergen-induced bronchoconstriction. Clin Exp Allergy 1993;23:528–531., , , .
- 75Evaluation of the effect of oral cetirizine on antigen-induced immediate asthmatic response. Ann Allergy 1990;65:501–503., , .
- 76The effect of azelastine on the infiltration of inflammatory cells into the bronchial mucosa and clinical changes in patients with bronchial asthma. Int Arch Allergy Immunol 1997;114:285–292., .
- 77Corticosteroid-sparing effect of azelastine in the management of bronchial asthma. Am J Respir Crit Care Med 1996;153:122–127., , , et al.
- 78Duration of action of a single dose of azelastine in patients with chronic asthma. J Asthma 1995;32:141–145., , .
- 79Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo controlled trial. J Allergy Clin Immunol. 1995;95:923–932., , , et al.
- 80Evaluation of cetirizine in patients with allergic rhinitis and perennial asthma. Ann Allergy Asthma Immunol 1996;76:440–446..
- 81Comparison of the bronchodilatory effects of cetirizine, albuterol and both together versus placebo in patients with mild to moderate asthma. J Allergy Clin Immunol 1995;96:174–181., , , et al.
- 82Is there a place for antihistamines in the treatment of perennial asthma? Pediatr Allergy Immunol 1993;4 Suppl 4:38–43..
- 83Terfenadine, a potent antihistamine H1-receptor antagonist in the treatment of grass pollen-sensitive asthma. Br J Pharmacol 1990;30:229–235., , , .
- 84Treatment of bronchial asthma with terfenadine; a randomized controlled trial. Br J Pharmacol 1987;24:743–746., , , , .
- 85Allergic bronchial asthma treated with loratadine. Fortschr Med 1993;111:76–78., , .
- 86Effect of a non-sedative antihistamine (loratadine) in moderate asthma. A double-blind, controlled clinical crossover trial. Allergy 1989;44:566–571., , , et al.
- 87Lack of effect of loratadine on moderate to severe asthma. Ann Allergy Asthma Immunol 1995;75:287–298., , .
- 88Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma. J Allergy Clin Immunol 1997;100(6 Pt 1):781–788., , , et al.
- 89ETAC Study Group. Allergic factors associated with the development of asthma and the influence of cetirizine on this progression in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Pediatr Allergy Immunol 1998;9:116–124.
- 90G-proteins in allergy. Clin Exp Allergy 1998;27 Suppl 2:1–7., , .